cytarabine has been researched along with Angiogenesis, Pathologic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itsumi, M; Kajikawa, M; Kato, H; Kawai, C; Kitakaze, K; Kuribayashi, F; Miyano, K; Okamoto, S; Yamauchi, A | 1 |
| Binner, M; Bornhäuser, M; Bray, LJ; Körner, Y; von Bonin, M; Werner, C | 1 |
| Li, Y; Mi, X; Niu, J; Song, Z; Zhang, Y | 1 |
| Berdel, WE; Frey, K; Giovannoni, L; Gutbrodt, KL; Klapper, W; Neri, D; Pabst, T; Schliemann, C | 1 |
| Cogle, CR; Drusbosky, L; Gars, E; McGee, C; Meacham, A; Scott, EW; Trujillo, A; Wise, E | 1 |
| Chung, SP; El Sayed, SM; El-Magd, RM; Fukui, K; Kagami, S; Sakai, T; Shishido, Y; Tran, DH; Watanabe, H; Yorita, K | 1 |
| Belleri, M; Presta, M; Ribatti, D; Vacca, A | 1 |
| Albitar, M; Andreeff, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, F; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Thomas, D | 1 |
| Contino-Pépin, C; Jasseron, S; Maurizis, JC; Pucci, B; Rapp, M | 1 |
| Asai, T; Kondo, M; Kuromi, K; Matsuda, A; Ogino, K; Oku, N; Shimizu, K; Shuto, S; Taki, T; Watanabe, K | 1 |
1 trial(s) available for cytarabine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Liposomes; Lymphokines; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Prognosis; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
9 other study(ies) available for cytarabine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Cell Cycle; Cell Line; Cell Movement; Coculture Techniques; Cytarabine; Drug Resistance, Neoplasm; Endothelial Cells; Gene Expression Regulation, Leukemic; Gene Knockout Techniques; HL-60 Cells; Humans; Indoles; Jurkat Cells; K562 Cells; Leukemia, Myeloid, Acute; Models, Biological; Neovascularization, Pathologic; Phosphorylation; Signal Transduction; U937 Cells; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
A three-dimensional
Topics: Benzylamines; Biomarkers; Cell Communication; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cyclams; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Heterocyclic Compounds; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Neovascularization, Pathologic; Receptors, CXCR4; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment | 2017 |
Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1/NF-κB/survivin signaling pathway.
Topics: Apoptosis; Carcinogenesis; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; GPI-Linked Proteins; HEK293 Cells; Humans; Inhibitor of Apoptosis Proteins; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinases; Neoplasm Proteins; Neovascularization, Pathologic; NF-kappa B; Paclitaxel; Signal Transduction; Survivin | 2018 |
Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biopsy; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytarabine; Disease Progression; Female; Fibronectins; HL-60 Cells; Humans; Interleukin-2; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Mice, SCID; Middle Aged; Neoplasm Transplantation; Neovascularization, Pathologic; Young Adult | 2013 |
Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Cytarabine; Drug Resistance, Neoplasm; Endothelial Cells; Gene Expression Regulation, Leukemic; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sulfonamides; Tumor Burden; Vascular Endothelial Growth Factor A | 2015 |
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Cisplatin; Citric Acid; Cytarabine; D-Amino-Acid Oxidase; Drug Resistance, Neoplasm; Energy Metabolism; Enzyme Inhibitors; Glioblastoma; Hexokinase; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mice; Neovascularization, Pathologic; Oxidative Stress; Pyruvates | 2012 |
Anti-angiogenic activity of the purine analog 6-thioguanine.
Topics: 2-Aminopurine; Acute Disease; Aged; Allantois; Anemia; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cattle; Cell Line, Transformed; Chick Embryo; Chorion; Cytarabine; Daunorubicin; Drug Evaluation; Endothelial Growth Factors; Endothelium, Vascular; Etoposide; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymphokines; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neovascularization, Pathologic; Neovascularization, Physiologic; Remission Induction; Stress, Mechanical; Thioguanine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting.
Topics: Acrylates; Animals; Cell Division; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Male; Methylamines; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oligopeptides; Prodrugs; Tissue Distribution | 2003 |
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cytarabine; Drug Delivery Systems; Liposomes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Phosphatidic Acids; Survival Analysis; Time Factors; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured | 2002 |